Vincerx Pharma (VINC) to Release Earnings on Friday

Vincerx Pharma (NASDAQ:VINC) is anticipated to post its quarterly earnings results before the market opens on Friday, April 4th. Analysts expect Vincerx Pharma to post earnings of ($2.60) per share for the quarter.

Vincerx Pharma Price Performance

VINC opened at $0.58 on Wednesday. The company’s 50 day simple moving average is $1.13 and its 200-day simple moving average is $4.92. The stock has a market capitalization of $1.29 million, a P/E ratio of -0.03 and a beta of 1.43. Vincerx Pharma has a one year low of $0.48 and a one year high of $136.80.

Vincerx Pharma Company Profile

Vincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors.